🇺🇸 FDA
Patent

US 10716809

Methods of producing enriched populations of tumor reactive T cells from peripheral blood

granted A61KA61K40/11A61K40/42

Quick answer

US patent 10716809 (Methods of producing enriched populations of tumor reactive T cells from peripheral blood) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jul 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jul 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K40/11, A61K40/42, A61P, A61P35/00